![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PathoFinder’s COVID-19 Test Gets CE Mark
PathoFinder’s COVID-19 Test Gets CE Mark
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
PathoFinder has received a CE mark for its RealAccurate Quadraplex Corona-plus polymerase chain reaction (PCR) kit for detection of the SARS-CoV-2 virus.
The PCR kit uses nasopharyngeal and oropharyngeal swabs and delivers results within two hours. In addition to detecting the COVID-19 virus, the diagnostic can also detect the Middle East Respiratory Syndrome (MERS) coronavirus.
The Netherlands-based company expects to deliver several thousand coronavirus tests to hospitals in the coming weeks.
Upcoming Events
-
21Oct